xabarchixabarchiABARCHI
Politics

FDA panel loosens restrictions for controversial peptides popular online

The vote marks a win for Health Secretary Robert F Kennedy who has said he's a big fan of the drugs, which haven't been well studied for human use.

An advisory panel for the US Food and Drug Administration (FDA) has voted to ease restrictions on certain controversial peptides, which have gained significant traction online despite limited research into their human applications.

The panel

health risksfdapeptidesonline wellnessdrug regulationbpckpvbiohacking

Cookies on xabarchi

We use cookies to remember your language and theme, and to count how many people are reading right now — that count is anonymous, lasts only while your browser is open, and cannot be tied to you or to another visit. With your permission we also measure how the site is read: Microsoft Clarity, which records page views and on-page interactions, and our own count of returning readers. Nothing that recognises you across visits is measured until you accept.